UpFrontPSMA: a randomized phase 2 study of sequential 177 Lu-PSMA-617 and docetaxel vs docetaxel in metastatic hormone-naïve prostate cancer (clinical trial protocol).
Nattakorn DhiantravanLouise EmmettAnthony M JoshuaDavid A PattisonRoslyn J FrancisScott WilliamsShahneen SandhuIan D DavisIan VelaNitika NehaMathias BresselDeclan G MurphyMichael S HofmanArun A AzadPublished in: BJU international (2021)
The results of this trial will generate data on the activity and safety of 177 Lu-PSMA-617 in men with de novo mHNPC in a randomized phase 2 design.
Keyphrases
- pet ct
- clinical trial
- prostate cancer
- open label
- phase ii
- pet imaging
- phase iii
- study protocol
- double blind
- locally advanced
- randomized controlled trial
- radical prostatectomy
- squamous cell carcinoma
- small cell lung cancer
- placebo controlled
- electronic health record
- big data
- middle aged
- positron emission tomography
- rectal cancer
- computed tomography
- radiation therapy
- data analysis